Caregiver distress is significantly attenuated when Alzheimer's disease patients are treated with a combination of memantine plus a cholinesterase inhibitor vs cholinesterase inhibitor monotherapy. Medscape Medical News (Source: Medscape Today Headlines)
Read the original Alzheimer's Group Resources article at MedWorm: Alzheimer's ...
Filed under - Alzheimer, alzheimers, news
No Comments so far.
Tags: alzheimers, alzheimers caregivers, alzheimers medication, alzheimers news
Related entries
Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.- Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
- Evaluation of an Assessment Battery for Estimating Dementia Caregiver Needs for Health and Social Care Services
- Long-term combination alzheimer’s therapy slows decline
